Also, they gave the names of the new appointees of the scientific advisory board. It was a lot of great news! Possible approval of the s/c already discussed with the FDA if the results are great. (They will be).
Nadar said he had 10 million shares left over (18mm but 8 r in escrow because of the lawsuit) so he doesn’t really have to sell any new shares of the 100 mm.